OVID (STOCKS)
Ovid Therapeutics Inc. Common Stock
$2.820000
+0.070000 (+2.55%)
Prev close: $2.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Margaret Alexander
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $368.59M
- Employees
- 23
- P/E (TTM)
- -10.62
- P/B (TTM)
- 2.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $7.25M |
| Benefits Costs and Expenses | $24.67M |
| Costs And Expenses | $24.67M |
| Operating Expenses | $49.69M |
| Research and Development | $25.58M |
| Other Operating Expenses | $24.11M |
| Operating Income/Loss | -$42.44M |
| Income/Loss From Continuing Operations After Tax | -$17.41M |
| Income/Loss From Continuing Operations Before Tax | -$17.41M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$17.41M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.41M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.41M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$272.00K |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $150.93M |
| Current Assets | $74.37M |
| Cash | $90.40M |
| Noncurrent Assets | $76.57M |
| Fixed Assets | $252.00K |
| Other Non-current Assets | $76.31M |
| Liabilities | $20.27M |
| Current Liabilities | $8.29M |
| Accounts Payable | $1.96M |
| Wages | $3.11M |
| Other Current Liabilities | $3.23M |
| Noncurrent Liabilities | $11.99M |
| Equity | $130.66M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $130.66M |
| Liabilities And Equity | $150.93M |
| Net Cash Flow From Operating Activities | -$38.33M |
| Net Cash Flow From Operating Activities, Continuing | -$38.33M |
| Net Cash Flow From Investing Activities | -$49.85M |
| Net Cash Flow From Investing Activities, Continuing | -$49.85M |
| Net Cash Flow From Financing Activities | $75.21M |
| Net Cash Flow From Financing Activities, Continuing | $75.21M |
| Net Cash Flow | -$12.98M |
| Net Cash Flow, Continuing | -$12.98M |
| Comprehensive Income/Loss | -$17.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.58M |
| Other Comprehensive Income/Loss | -$17.58M |